Novartis Access – Need for social metrics

Professor Richard Laing, an expert on access-to-medicine programs, says the pharma industry needs to better measure the impact of our programs. Here he comments on the need to measure social programs.

To learn more visit: http://socialbusiness.novartis.com

© 2017 Novartis AG